Physician profile
Ashlyn N Smith
NPI 1881978963
$30,529.96
in general payments reported to CMS, 2019-2025
10 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,186 · 2022: $10K · 2023: $244 · 2024: $279 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,154 · Travel and Lodging: $3,126 · Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,153.67 |
| Travel and Lodging | $3,125.76 |
| Food and Beverage | $1,690.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14,166.61 | 2021-2022 | |
| Insulet Corporation | $9,719.41 | 2021-2025 | Omnipod |
| Abbott Laboratories | $2,766.65 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $2,663.00 | 2021-2022 | |
| Corcept Therapeutics | $498.13 | 2023-2025 | Korlym |
| Amgen INC. | $321.07 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $224.08 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2022 | |
| Ascensia Diabetes Care US INC. | $46.02 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlyn Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.